EP1675550A4 - Schemas posologiques therapeutiques pour une administration de combinaisons de medicaments - Google Patents
Schemas posologiques therapeutiques pour une administration de combinaisons de medicamentsInfo
- Publication number
- EP1675550A4 EP1675550A4 EP04788933A EP04788933A EP1675550A4 EP 1675550 A4 EP1675550 A4 EP 1675550A4 EP 04788933 A EP04788933 A EP 04788933A EP 04788933 A EP04788933 A EP 04788933A EP 1675550 A4 EP1675550 A4 EP 1675550A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- drug combinations
- therapeutic regimens
- administering drug
- administering
- regimens
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/40—Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Obesity (AREA)
- Otolaryngology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/670,488 US20040220153A1 (en) | 2002-09-24 | 2003-09-24 | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
US51241503P | 2003-10-15 | 2003-10-15 | |
US52044603P | 2003-11-13 | 2003-11-13 | |
US10/777,517 US20040229849A1 (en) | 2002-09-24 | 2004-02-12 | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
US10/777,518 US20040224876A1 (en) | 2003-02-14 | 2004-02-12 | Combination therapy for the treatment of immunoinflammatory disorders |
US55749604P | 2004-03-30 | 2004-03-30 | |
US10/944,574 US20050137185A1 (en) | 2003-09-18 | 2004-09-17 | Combinations of drugs for the treatment of neoplasms |
US10/947,455 US20050153947A1 (en) | 2002-09-24 | 2004-09-20 | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
PCT/US2004/031195 WO2005030132A2 (fr) | 2003-09-24 | 2004-09-23 | Schemas posologiques therapeutiques pour une administration de combinaisons de medicaments |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1675550A2 EP1675550A2 (fr) | 2006-07-05 |
EP1675550A4 true EP1675550A4 (fr) | 2007-10-10 |
Family
ID=46123823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04788933A Withdrawn EP1675550A4 (fr) | 2003-09-24 | 2004-09-23 | Schemas posologiques therapeutiques pour une administration de combinaisons de medicaments |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1675550A4 (fr) |
JP (1) | JP2007517766A (fr) |
KR (1) | KR20060076319A (fr) |
AU (1) | AU2004275777A1 (fr) |
BR (1) | BRPI0414719A (fr) |
CA (1) | CA2538023A1 (fr) |
IS (1) | IS8413A (fr) |
MX (1) | MXPA06003320A (fr) |
NO (1) | NO20061284L (fr) |
WO (1) | WO2005030132A2 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050110634A (ko) * | 2003-02-14 | 2005-11-23 | 콤비네이토릭스, 인코포레이티드 | 면역 염증 질병의 치료를 위한 조합 치료법 |
ATE420881T1 (de) | 2003-09-17 | 2009-01-15 | Janssen Pharmaceutica Nv | Kondensierte heterocyclische verbindungen als modulatoren des serotoninrezeptors |
TW200517114A (en) * | 2003-10-15 | 2005-06-01 | Combinatorx Inc | Methods and reagents for the treatment of immunoinflammatory disorders |
CN1980649A (zh) * | 2004-05-17 | 2007-06-13 | 康宾纳特克斯公司 | 治疗免疫炎性疾病的方法和试药 |
US7598255B2 (en) | 2005-08-04 | 2009-10-06 | Janssen Pharmaceutica Nv | Pyrimidine compounds as serotonin receptor modulators |
TW200932240A (en) * | 2007-10-25 | 2009-08-01 | Astellas Pharma Inc | Pharmaceutical composition containing lipophilic substance which inhibits IL-2 production |
KR101546596B1 (ko) * | 2011-01-04 | 2015-08-21 | 이스타 파머슈티컬즈, 인크. | 베포타스틴 조성물 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003006026A1 (fr) * | 2001-07-09 | 2003-01-23 | Combinatorx, Incorporated | Combinaisons pour le traitement de troubles inflammatoires |
WO2003082285A1 (fr) * | 2002-04-03 | 2003-10-09 | Boehringer Ingelheim International Gmbh | Combinaisons d'epinastine, de belladone et de pseudoephedrine en tant que nouvelles formulations pharmaceutiques |
WO2003084510A1 (fr) * | 2002-04-04 | 2003-10-16 | Dr. Reddy's Laboratories Ltd. | Nouvelles compositions pharmaceutiques pour une combinaison antihistaminique-decongestive et procede de fabrication de ces compositions |
WO2003088952A1 (fr) * | 2002-04-15 | 2003-10-30 | Adams Laboratories, Inc. | Liberation reguliere de medicaments combines de guaifenesin |
WO2004017938A2 (fr) * | 2002-08-23 | 2004-03-04 | Ranbaxy Laboratories Limited | Forme galenique a liberation controlee de nitrofurantoine |
WO2004030618A2 (fr) * | 2002-09-24 | 2004-04-15 | Combinatorx, Incorporated | Methodes et reactifs destines au traitement de maladies et de troubles associes a des niveaux accrus de cytokines pro-inflammatoires |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4618677A (en) * | 1984-05-31 | 1986-10-21 | Boehringer Ingelheim Limited | Substituted phenylalkyl-(piperazinyl or homopiperazinyl)alkyl-thiols and -thiocarbamates useful for the treatment of immunological, inflammatory, and allergic disorders |
TW483763B (en) * | 1994-09-02 | 2002-04-21 | Astra Ab | Pharmaceutical composition comprising of ramipril and dihydropyridine compound |
JP3962108B2 (ja) * | 1995-04-03 | 2007-08-22 | 中外製薬株式会社 | スクラルファート含有製剤組成物 |
IL150368A0 (en) * | 1999-12-23 | 2002-12-01 | Nitromed Inc | Nitrosated and nitrosylated cyclooxygenase-2-inhibitors, compositions and methods of use |
-
2004
- 2004-09-23 KR KR1020067007818A patent/KR20060076319A/ko not_active Application Discontinuation
- 2004-09-23 EP EP04788933A patent/EP1675550A4/fr not_active Withdrawn
- 2004-09-23 JP JP2006528154A patent/JP2007517766A/ja active Pending
- 2004-09-23 BR BRPI0414719-7A patent/BRPI0414719A/pt not_active IP Right Cessation
- 2004-09-23 AU AU2004275777A patent/AU2004275777A1/en not_active Abandoned
- 2004-09-23 WO PCT/US2004/031195 patent/WO2005030132A2/fr active Application Filing
- 2004-09-23 MX MXPA06003320A patent/MXPA06003320A/es not_active Application Discontinuation
- 2004-09-23 CA CA002538023A patent/CA2538023A1/fr not_active Abandoned
-
2006
- 2006-03-21 NO NO20061284A patent/NO20061284L/no not_active Application Discontinuation
- 2006-04-12 IS IS8413A patent/IS8413A/is unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003006026A1 (fr) * | 2001-07-09 | 2003-01-23 | Combinatorx, Incorporated | Combinaisons pour le traitement de troubles inflammatoires |
WO2003082285A1 (fr) * | 2002-04-03 | 2003-10-09 | Boehringer Ingelheim International Gmbh | Combinaisons d'epinastine, de belladone et de pseudoephedrine en tant que nouvelles formulations pharmaceutiques |
WO2003084510A1 (fr) * | 2002-04-04 | 2003-10-16 | Dr. Reddy's Laboratories Ltd. | Nouvelles compositions pharmaceutiques pour une combinaison antihistaminique-decongestive et procede de fabrication de ces compositions |
WO2003088952A1 (fr) * | 2002-04-15 | 2003-10-30 | Adams Laboratories, Inc. | Liberation reguliere de medicaments combines de guaifenesin |
WO2004017938A2 (fr) * | 2002-08-23 | 2004-03-04 | Ranbaxy Laboratories Limited | Forme galenique a liberation controlee de nitrofurantoine |
WO2004030618A2 (fr) * | 2002-09-24 | 2004-04-15 | Combinatorx, Incorporated | Methodes et reactifs destines au traitement de maladies et de troubles associes a des niveaux accrus de cytokines pro-inflammatoires |
Non-Patent Citations (1)
Title |
---|
HOLZGREVE H: "Safety profile of the combination of verapamil and trandolapril", JOURNAL OF HYPERTENSION. SUPPLEMENT, RAPID SCIENCE PUBLISHERS,, US, vol. 15, no. suppl 2, 1997, pages s51 - s53, XP009088649, ISSN: 0952-1178 * |
Also Published As
Publication number | Publication date |
---|---|
BRPI0414719A (pt) | 2006-11-21 |
IS8413A (is) | 2006-04-12 |
WO2005030132A2 (fr) | 2005-04-07 |
WO2005030132A3 (fr) | 2006-10-12 |
AU2004275777A1 (en) | 2005-04-07 |
KR20060076319A (ko) | 2006-07-04 |
CA2538023A1 (fr) | 2005-04-07 |
EP1675550A2 (fr) | 2006-07-05 |
MXPA06003320A (es) | 2006-06-08 |
NO20061284L (no) | 2006-06-22 |
JP2007517766A (ja) | 2007-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1510207A4 (fr) | Medicaments therapeutiques destines au diabete | |
GB0303910D0 (en) | Therapeutic agents | |
AU2003234634A8 (en) | Drug therapy for celiac sprue | |
GB0308318D0 (en) | Therapeutic agents | |
GB0314079D0 (en) | Therapeutic agents | |
GB0314057D0 (en) | Therapeutic agents | |
HK1095036A1 (en) | Virus therapeutic drug | |
EP1706129A4 (fr) | Traitement medicamenteux contre la sprue coeliaque | |
GB0313250D0 (en) | Therapeutic agents | |
GB0314049D0 (en) | Therapeutic agents | |
GB0314129D0 (en) | Therapeutic agents | |
GB0311859D0 (en) | Therapeutic agents | |
GB0311201D0 (en) | Therapeutic agents | |
GB0301350D0 (en) | Therapeutic agents | |
EP1675550A4 (fr) | Schemas posologiques therapeutiques pour une administration de combinaisons de medicaments | |
GB0314130D0 (en) | Therapeutic agents | |
IL174285A0 (en) | Therapeutic regimens for administering drug combinations | |
ZA200603126B (en) | Pharmaceutical compositions for therapeutic use | |
EP1485077A4 (fr) | Therapie par association de medicaments | |
GB0314075D0 (en) | Therapeutic agents | |
GB0304524D0 (en) | Therapeutic agents | |
GB0314078D0 (en) | Therapeutic agents | |
GB0327397D0 (en) | Method of administering medicament | |
GB0305283D0 (en) | Therapeutic agents | |
GB0305823D0 (en) | Therapeutic agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20060424 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL HR LT LV MK |
|
PUAK | Availability of information related to the publication of the international search report |
Free format text: ORIGINAL CODE: 0009015 |
|
RAX | Requested extension states of the european patent have changed |
Extension state: LV Payment date: 20060424 Extension state: LT Payment date: 20060424 Extension state: HR Payment date: 20060424 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20070907 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 45/06 20060101ALI20070903BHEP Ipc: A61K 6/00 20060101AFI20050411BHEP |
|
17Q | First examination report despatched |
Effective date: 20071123 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20091217 |